Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT05918770

Side Effects Screening and Early Intervention to Impact in Quality of Life of Gynaecological Cancer Patients

Telemedicine-guided Patients Reported Outcome Measures (PROMs): Side Effects Screening and Early Intervention to Impact in Quality of Life of Gynaecological Cancer Patients

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
168 (estimated)
Sponsor
Hospital Universitario 12 de Octubre · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this randomized study is to assess the impact on self-perceived quality of life (QoL) of systematic screening and early treatment of aftereffects in patients with gynaecological cancers. The main question it aims to answer is if systematic screening with validated questionaries (see in detailed description), diagnosis and early treatment of lower-limb lymphoedema, anxiety-depression, sexual dysfunction and sarcopenia-malnutrition all have a positive impact on the self-perceived QoL by gynaecological cancer patients. Participants will access the screening questionnaires and QoL questionaries on a free online app on their mobile devices. In the experimental group, in case of positive screening, patients will be referred to specialised care to early treatment of the aftereffects. Researchers will compare this group with standard usual care (opportunistic treatment) to see if systematic screening and early treatment lead to a better QoL.

Detailed description

validated screening scales used: Gynecologic Cancer Lymphedema Questionnaire (GCLQ) Hospital Anxiety and Depression Scale (HADS) Sexual Function Abbreviated Index (IFSFA-6) Short Nutritional Assessment Questionnaire (SNAQ) Sarcopenia Formulary (SARC-F) along with self-perceived quality of life questionnaires from EORTC: QLQ-C30 EN-24 or OV-28 or CX-24

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTsystematic screening and early treatmentin case of positive screening, the online app will alert and the patient will be referred to the corresponding area for diagnosis and early treatment (Rehabilitation, Psycho-oncology, Sexual health and Nutrition

Timeline

Start date
2023-09-01
Primary completion
2026-09-01
Completion
2026-09-01
First posted
2023-06-26
Last updated
2023-06-26

Source: ClinicalTrials.gov record NCT05918770. Inclusion in this directory is not an endorsement.